In addition, FEN1/USP7/MDM2 axis proposed in this study showed targeted value for HCC treatment, while the deeper regulatory mechanisms should be further investigated by more molecular assays and strategies. This evidence concerns the gene USP7 and hepatocellular carcinoma.